SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-108899
Filing Date
2021-04-07
Accepted
2021-04-07 16:26:01
Documents
4
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d72093ddef14a.htm DEF 14A 548711
2 GRAPHIC g72093g02k50gray.jpg GRAPHIC 14010
3 GRAPHIC g72093g67u04.jpg GRAPHIC 47150
4 GRAPHIC g72093g99y44.jpg GRAPHIC 30556
  Complete submission text file 0001193125-21-108899.txt   670194
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36167 | Film No.: 21812417
SIC: 2834 Pharmaceutical Preparations